Answers are grounded in this paper and cite their sources.
Authors respond to comments on survival outcomes and patient traits in melanoma from a national registry.
Response to “Comment on ‘Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden’” by Qi at al from the authors of the original article.
No takes yet. Share an insight, caveat, or question.
Marjanovic et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: